FDA Brief

Warning letters Food

FDA warning letter to

Supplement Science Corp. d/b/a Condemned Labz

High riskIssued Sep 22, 2021Posted Sep 28, 2021Office of Human and Animal Food Operations East – Division 1

FDA warned Condemned Labz that five supplement products were unapproved new drugs and misbranded, and two were adulterated.

What happened

FDA reviewed the company’s website and Facebook page in June, July, and September 2021. FDA found product pages and blog or social media posts claiming the products reduce blood sugar, control insulin, treat thyroid disorders, or increase pain tolerance, which made them unapproved new drugs and misbranded. FDA also said Arsyn and ConvictStim are adulterated dietary supplements because they contain higenamine or 2-aminoisoheptane HCl (and Arsyn also hordenine HCl), ingredients FDA treats as unsafe or unapproved.

What FDA found

  1. Website and social media claims that the products treat or manage disease make them unapproved new drugs.

    section 201(g)(1)(B), 201(p), 301(d), 505(a) of the Act [21 U.S.C. 321(g)(1)(B), 321(p), 331(d), 355(a)]
  2. The products are misbranded because they lack adequate directions for use for diseases that laypeople cannot safely self-treat.

    section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)]
  3. ConvictStim contains higenamine, a new dietary ingredient for which FDA says the required safety notification was not submitted.

    section 413(a)(2) of the Act and 21 CFR 190.6; sections 402(f) and 413(a) [21 U.S.C. 350b(a)(2), 342(f), 350b(a)]
  4. FDA says the evidence does not show higenamine is safe and points to serious heart toxicity risk.

    section 402(f)(1)(B) of the Act [21 U.S.C. 342(f)(1)(B)]
  5. Arsyn and ConvictStim contain 2-aminoisoheptane HCl, and Arsyn also contains hordenine HCl and higenamine HCl, which FDA treats as unsafe food additives.

    section 402(a)(2)(C)(i) and 409(a) of the Act [21 U.S.C. 342(a)(2)(C)(i), 348(a)]

What FDA wants

FDA tells the company to reply in writing within 15 working days with the specific steps taken to address the violations and prevent recurrence, plus documentation. If corrections cannot be completed in that time, the company must explain the delay and give a completion date, or explain why it believes the products are not in violation.

Who should pay attention

  • retailers and online marketplaces selling Condemned Labz products
  • brands that use higenamine or 2-aminoisoheptane HCl in supplements
  • companies making disease-related claims for supplement products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk